NCT06347926 2025-11-18
EVABIOSEIN
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Recruiting
Clinical Trials
11 trialsNCT03307044 2023-03-20
Fractional CO2 Laser Therapy for Survivors of Breast Malignancies
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT03666819 2023-01-06
Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy
Mayo Clinic
Phase 2 Withdrawn
NCT03257670 2021-09-28
BCLS
University of Cincinnati
Phase NA Unknown
NCT03628092 2020-03-12
LAAVA2
Royal North Shore Hospital
Phase NA Unknown
NCT03738605 2019-07-30
Vaginal Laser Therapy in Breast Cancer Survivors
National and Kapodistrian University of Athens
Phase NA Unknown
NCT02150525 2018-08-09
Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
NCT00981305 2017-08-07
Impact of Lactate-Containing Vaginal Lubricant on Sexual Dysfunction in Young Breast Cancer Survivors
Seoul National University Hospital
Phase 3 Completed
NCT01539317 2017-04-14
Therapy to Prevent Sexual Pain in Breast Cancer Survivors
OHSU Knight Cancer Institute
Phase 3 Completed
NCT01697345 2014-01-24
Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy
Creighton University
Phase EARLY_PHASE1 Completed
NCT01122342 2010-05-13
Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.
University of Vermont
Phase 1/2 Suspended